Exact Mass: 419.2672

Exact Mass Matches: 419.2672

Found 47 metabolites which its exact mass value is equals to given mass value 419.2672, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Arachidonoyl Aspartic acid

2-[(1-Hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]butanedioate

C24H37NO5 (419.2672)


N-arachidonoyl aspartic acid, also known as N-arachidonoyl aspartate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Aspartic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   
   

11,12,13-trihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione

11,12,13-trihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione

C24H37NO5 (419.2672)


   
   

11-hydroxydaphnigracine|methyl (4SR,6RS,6RS,8aRS,9RS,10aRS,11SR)-2,3,4,5,5,6,6,7,8,8a,9,10-dodecahydro-6,6-dihydroxy-2-methyl-6-(1-methylethyl)-1H,4H-spiro{4,10a-methanopentaleno[1,6-cd]azonine-11,3-pyran}-9-carboxylate

11-hydroxydaphnigracine|methyl (4SR,6RS,6RS,8aRS,9RS,10aRS,11SR)-2,3,4,5,5,6,6,7,8,8a,9,10-dodecahydro-6,6-dihydroxy-2-methyl-6-(1-methylethyl)-1H,4H-spiro{4,10a-methanopentaleno[1,6-cd]azonine-11,3-pyran}-9-carboxylate

C24H37NO5 (419.2672)


   
   

Sinulamine III

Sinulamine III

C24H37NO5 (419.2672)


   

daphlongamine I

daphlongamine I

C24H37NO5 (419.2672)


   

aspochalasin U

aspochalasin U

C24H37NO5 (419.2672)


   

Sinulamine II

Sinulamine II

C24H37NO5 (419.2672)


   

C24H37NO5_(7E)-11,12,13-Trihydroxy-3-isobutyl-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

NCGC00347828-02_C24H37NO5_(7E)-11,12,13-Trihydroxy-3-isobutyl-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

C24H37NO5 (419.2672)


   

CP-728663

CP-728663

C26H33N3O2 (419.2573)


CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5898; ORIGINAL_PRECURSOR_SCAN_NO 5894 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5936; ORIGINAL_PRECURSOR_SCAN_NO 5934 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5937; ORIGINAL_PRECURSOR_SCAN_NO 5935 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5952; ORIGINAL_PRECURSOR_SCAN_NO 5951 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5960; ORIGINAL_PRECURSOR_SCAN_NO 5958 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5960; ORIGINAL_PRECURSOR_SCAN_NO 5959

   
   
   
   

4,5,6-Trihydroxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

4,5,6-Trihydroxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

C24H37NO5 (419.2672)


   

N-Arachidonoyl Aspartic acid

N-Arachidonoyl Aspartic acid

C24H37NO5 (419.2672)


   

N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cycloheptanecarboxamide

N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cycloheptanecarboxamide

C26H33N3O2 (419.2573)


   

(E)-3-hydroxy-2-(undecanoylamino)dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(undecanoylamino)dec-4-ene-1-sulfonic acid

C21H41NO5S (419.2705)


   

(E)-2-(decanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid

(E)-2-(decanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid

C21H41NO5S (419.2705)


   

NA-2AAA 18:4(6Z,9Z,12Z,15Z)

NA-2AAA 18:4(6Z,9Z,12Z,15Z)

C24H37NO5 (419.2672)


   

NA-Asp 20:4(5Z,8Z,11Z,14Z)

NA-Asp 20:4(5Z,8Z,11Z,14Z)

C24H37NO5 (419.2672)


   

NA-DOPA 15:1(9Z)

NA-DOPA 15:1(9Z)

C24H37NO5 (419.2672)


   

ST 22:2;O3;Gly

ST 22:2;O3;Gly

C24H37NO5 (419.2672)


   

14-debenzoylfranchetine

NA

C24H37NO5 (419.2672)


{"Ingredient_id": "HBIN001401","Ingredient_name": "14-debenzoylfranchetine","Alias": "NA","Ingredient_formula": "C24H37NO5","Ingredient_Smile": "CCN1CC2(CCC(C34C2CC(=C5CC(C6CC3C5C6O)OC)OC41)OC)COC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4805","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(4e,6z)-n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

(4e,6z)-n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C24H37NO5 (419.2672)


   

(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C24H37NO5 (419.2672)


   

n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

(4r,5r,10as,13s,13as,14s,16ar)-4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

(4r,5r,10as,13s,13as,14s,16ar)-4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

C24H37NO5 (419.2672)


   

9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

C24H37NO5 (419.2672)


   

(9z,13e)-18-[(dimethylamino)methyl]-4,9,13-trimethyl-17-oxo-5,16-dioxatricyclo[13.3.0.0⁴,⁶]octadeca-9,13-dien-3-yl acetate

(9z,13e)-18-[(dimethylamino)methyl]-4,9,13-trimethyl-17-oxo-5,16-dioxatricyclo[13.3.0.0⁴,⁶]octadeca-9,13-dien-3-yl acetate

C24H37NO5 (419.2672)


   

n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

methyl 7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl 7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

(1r,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1r,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C24H37NO5 (419.2672)


   

methyl (1s,4as,4bs,7e,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4as,4bs,7e,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

(1s,2r,3r,4s,5s,6s,8r,9s,10r,13r,16s,17r)-11-ethyl-4-hydroxy-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one

(1s,2r,3r,4s,5s,6s,8r,9s,10r,13r,16s,17r)-11-ethyl-4-hydroxy-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one

C24H37NO5 (419.2672)


   

1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C24H37NO5 (419.2672)


   

(1r,5r,6s,7r,10s,11r,12s,15r,16s)-9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

(1r,5r,6s,7r,10s,11r,12s,15r,16s)-9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

C24H37NO5 (419.2672)


   

6-acetyl-3-[(dimethylamino)methyl]-9,13-dimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,8h,11h,12h,14ah-cyclotrideca[b]furan-5-yl acetate

6-acetyl-3-[(dimethylamino)methyl]-9,13-dimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,8h,11h,12h,14ah-cyclotrideca[b]furan-5-yl acetate

C24H37NO5 (419.2672)


   

methyl (1s,4as,4bs,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4as,4bs,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

methyl (1s,4ar,4bs,7e,8r,8as,10ar)-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4ar,4bs,7e,8r,8as,10ar)-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

(1r,2s,3s,4s,5s,6r,8r,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1r,2s,3s,4s,5s,6r,8r,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C24H37NO5 (419.2672)


   

(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C24H37NO5 (419.2672)


   

4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

C24H37NO5 (419.2672)